Extracorporeal organ support following trauma: The dawn of a new era in combat casualty critical care

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 2 SUPPL. 2, 2013, Pages

  Neff, Lucas P ^a,c   Cannon, Jeremy W ^b,c   Stewart, Ian J ^b   Batchinsky, Andriy I ^e   Zonies, David H ^d   Pamplin, Jeremy C ^b   Chung, Kevin K ^c,e  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d LANDSTUHL REGIONAL MEDICAL CENTER   (Germany)

^e US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; POLYMYXIN B; PROSTACYCLIN;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BATTLE INJURY; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; EXTRACORPOREAL OXYGENATION; HEALTH CARE DELIVERY; HEMOPERFUSION; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LUNG RESECTION; LUNG TRANSPLANTATION; MECHANICAL VENTILATOR; OUT OF HOSPITAL CARDIAC ARREST; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SEPSIS; SHOCK;

CRITICAL CARE; HEMOFILTRATION; HUMANS; MILITARY MEDICINE; MULTIPLE ORGAN FAILURE; PLASMA EXCHANGE; RENAL REPLACEMENT THERAPY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; WOUNDS AND INJURIES;

EID: 84881416623     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318299d0cb     Document Type: Review

References (98)

1. Bellamy RF, Maningas PA, Vayer JS. Epidemiology of trauma: military experience. Ann Emerg Med. 1986;15:1384-1388.
2. Eastridge BJ, Hardin M, Cantrell J, et al. Died of wounds on the battlefield: causation and implications for improving combat casualty care. J Trauma. 2011;71(Suppl 1):S4-S8.
3. Martin M, Oh J, Currier H, et al. An analysis of in-hospital deaths at a modern combat support hospital. J Trauma. 2009;66(Suppl 4):S51-S60; discussion S60-S61.
4. Kelly JF, Ritenour AE, McLaughlin DF, et al. Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003-2004 versus 2006. J Trauma. 2008;64(Suppl 2):S21-S26; discussion S26-S27.
5. Chovanes J, Cannon JW, Nunez TC. The evolution of damage control surgery. Surg Clin North Am. 2012;92:859-875, vii-viii.
6. Cohen MJ. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am. 2012;92:877-891, viii.
7. Cannon JW, Chung KK, King DR. Advanced technologies in trauma critical care management. Surg Clin North Am. 2012;92:903-923, viii.
8. McCunn M, Reynolds HN, Reuter J, et al. Continuous renal replacement therapy in patients following traumatic injury. Int J Artif Organs. 2006; 29:166-186.
9. Batchinsky AI, Jordan BS, Regn D, et al. Respiratory dialysis: reduction in dependence on mechanical ventilation by venovenous extracorporeal CO2 removal. Crit Care Med. 2011;39:1382-1387.
10. Arlt M, PhilippA, Voelkel S, et al. Extracorporealmembrane oxygenation in severe trauma patients with bleedingshock. Resuscitation. 2010;81:804-809.
11. Lee CC, Marill KA, Carter WA, Crupi RS. A current concept of traumainduced multiorgan failure. Ann Emerg Med. 2001;38:170-176.
12. GaoL,BarnesKC.Recent advances in genetic predisposition to clinical acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2009;296:L713-L725.
13. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
14. Rimmele T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care. 2011;15:205.
15. Cannon JW, Zonies DH, Benfield RJ, Elster EA,Wanek SM. Advanced enroute critical care during combat operations. Bull Am Coll Surg. 2011; 96:21-29.
16. Stoney WS. Evolution of cardiopulmonary bypass. Circulation. 2009;119: 2844-2853.
17. Hill JD, OBrien TG,Murray JJ, et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome).Use of the Bramson membrane lung. N Engl J Med. 1972;286:629-634.
18. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA. 1979;242:2193-2196.
19. Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med. 1994;149(2 pt 1):295-305.
20. PeekGJ,Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351-1363.
21. Freebairn R, McHugh G, Hickling K. Extracorporeal membrane oxygenation for ARDS due to 2009 influenza A(H1N1). JAMA. 2010;303: 941-942; author reply 942.
22. Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365:1905-1914.
23. Fang R, Allan PF, Womble SG, et al. Closing the care in the air capability gap for severe lung injury: the Landstuhl Acute Lung Rescue Team and extracorporeal lung support. J Trauma. 2011;71(Suppl 1):S91-S97.
24. Fang R, Dorlac GR, Allan PF, Dorlac WC. Intercontinental aeromedical evacuation of patients with traumatic brain injuries during Operations Iraqi Freedom and Enduring Freedom. Neurosurg Focus. 2010;28:E11.
25. Bein T, Graf B, Weber-Carstens S. Ventilatory support versus ECMO for severe adult respiratory failure. Lancet. 2010;375:549-550; author reply 551.
26. Bein T, Weber F, Philipp A, et al. A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med. 2006;34:1372-1377.
27. Beninati W, Meyer MT, Carter TE. The critical care air transport program. Crit Care Med. 2008;36(Suppl 7):S370-S376.
28. Bridges E, Evers K. Wartime critical care air transport. Mil Med. 2009; 174:370-375.
29. Dorlac GR, Fang R, Pruitt VM, et al. Air transport of patients with severe lung injury: development and utilization of the Acute Lung Rescue Team. J Trauma. 2009;66(Suppl 4):S164-S171.
30. Bein T, Zonies D, Philipp A, et al. Transportable extracorporeal lung support for rescue of severe respiratory failure in combat casualties. J Trauma Acute Care Surg. 2012;73:1450-1456.
31. Coppola CP, Tyree M, Larry K, DiGeronimo R. A 22-year experience in global transport extracorporeal membrane oxygenation. J Pediatr Surg. 2008;43:46-52; discussion 52.
32. Renz EM, Cancio LC, Barillo DJ, et al. Long range transport of war-related burn casualties. J Trauma. 2008;64(Suppl 2):S136-S144; discussion S144-S145.
33. Sherlock JE, Yoon Y, Ledwith JW, Letteri JM. Respiratory gas exchange during hemodialysis. Proc Clin Dial Transplant Forum. 1972;2:171-174.
34. Gattinoni L, Kolobow T, Tomlinson T, et al. Low-frequency positive pressure ventilation with extracorporeal carbon dioxide removal (LFPPVECCO2R): an experimental study. Anesth Analg. 1978;57:470-477.
35. KolobowT,Gattinoni L,TomlinsonTA, Pierce JE.Control of breathing using an extracorporeal membrane lung. Anesthesiology. 1977;46:138-141.
36. Pesenti A, Rossi GP, Pelosi P, Brazzi L, Gattinoni L. Percutaneous extracorporeal CO2 removal in a patient with bullous emphysema with recurrent bilateral pneumothoraces and respiratory failure. Anesthesiology. 1990;72:571-573.
37. Zwischenberger JB, TaoW, Bidani A. Intravascular membrane oxygenator and carbon dioxide removal devices: a review of performance and improvements. ASAIO J. 1999;45:41-46.
38. Cardenas VJ Jr, Lynch JE, Ates R, Miller L, Zwischenberger JB. Venovenous carbon dioxide removal in chronic obstructive pulmonary disease: experience in one patient. ASAIO J. 2009;55:420-422.
39. Cardenas VJ Jr, Miller L, Lynch JE, Anderson MJ, Zwischenberger JB. Percutaneous venovenous CO2 removal with regional anticoagulation in an ovine model. ASAIO J. 2006;52:467-470.
40. Ruberto F, Pugliese F, DAlio A, et al. Extracorporeal removal CO2 using a venovenous, low-flow system (Decapsmart) in a lung transplanted patient: a case report. Transplant Proc. 2009;41:1412-1414.
41. Wearden PD, Federspiel WJ, Morley SW, et al. Respiratory dialysis with an active-mixing extracorporeal carbon dioxide removal system in a chronic sheep study. Intensive Care Med. 2012;38:1705-1711.
42. Zanella A, Patroniti N, Isgro S, et al. Blood acidification enhances carbon dioxide removal of membrane lung: an experimental study. Intensive Care Med. 2009;35:1484-1487.
43. Terragni PP, Del Sorbo L, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology. 2009;111:826-835.
44. Valenza F, Rosso L, Gatti S, et al. Extracorporeal lung perfusion and ventilation to improve donor lung function and increase the number of organs available for transplantation. Transplant Proc. 2012;44:1826-1829.
45. Moscatelli A, Ottonello G, Nahum L, et al. Noninvasive ventilation and lowflow veno-venous extracorporeal carbon dioxide removal as a bridge to lung transplantation in a child with refractory hypercapnic respiratory failure due to bronchiolitis obliterans. Pediatr Crit Care Med. 2010;11:e8-e12.
46. Bywaters EG, Beall D. Crush injuries with impairment of renal function. 1941. J Am Soc Nephrol. 1998;9:322-332.
47. ChungKK, PerkinsRM, Oliver JD3rd. Renal replacement therapy in support of combat operations. Crit Care Med. 2008;36(Suppl 7):S365-S369.
48. Smith LHJr, Post RS, Teschan PE, et al. Post-traumatic renal insufficiency in military casualties. II. Management, use of an artificial kidney, prognosis. Am J Med. 1955;18:187-198.
49. Conger JD.Acontrolled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma. 1975;15:1056-1063.
50. Stewart IJ, Tilley MA, Cotant CL, et al. Association of AKI with adverse outcomes in burned military casualties. Clin JAmSoc Nephrol. 2012; 7:199-206.
51. ChungKK, JuncosLA,Wolf SE, et al.Continuous renal replacement therapy improves survival in severely burned military casualties with acute kidney injury. J Trauma. 2008;64(Suppl 2):S179-S185; discussion S185-S187.
52. Bihorac A, Delano MJ, Schold JD, et al. Incidence, clinical predictors, genomics, and outcome of acute kidney injury among trauma patients. Ann Surg. 2010;252:158-165.
53. Wohlauer MV, Sauaia A, Moore EE, et al. Acute kidney injury and posttrauma multiple organ failure: the canary in the coal mine. J Trauma Acute Care Surg. 2012;72:373-378; discussion 379-380.
54. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failurewhen continuous renal replacement therapy is applied early vs. late. Intensive Care Med. 1999;25:805-813.
55. Perkins R, Simon J, Jayakumar A, et al. Renal replacement therapy in support of Operation Iraqi Freedom: a tri-service perspective. Mil Med. 2008;173:1115-1121.
56. Perkins RM, George R, Fox CR, Yuan CM. Successful CAVH in an austere environment using readily available disposable hospital supplies. Nephrol Dial Transplant. 2007;22:1241-1246.
57. Pina JS, Moghadam S, Cushner HM, Beilman GJ, McAlister VC. Intheater peritoneal dialysis for combat-related renal failure. J Trauma. 2010;68:1253-1256.
58. Zonies DH, DuBose J, Elterman J, et al. Early implementation of continuous renal replacement therapy optimizes casualty evacuation for combat-related acute kidney injury. J TraumaAcute Care Surg. 2012;MilitaryHealth System Research Symposium (MHSRS).
59. Friedrich JO,WaldR,BagshawSM, BurnsKE,AdhikariNK. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care. 2012;16:R146.
60. Brunet S, Leblanc M, Geadah D, et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis. 1999;34:486-492.
61. Davenport A. Management of acute kidney injury in neurotrauma. Hemodial Int. 2010;14(Suppl 1):S27-S31.
62. Davies SP, Reaveley DA, Brown EA, Kox WJ. Amino acid clearances and daily losses in patients with acute renal failure treated by continuous arteriovenous hemodialysis. Crit Care Med. 1991;19:1510-1515.
63. Fletcher JJ,BergmanK, FeuchtEC,Blostein P.Continuous renal replacement therapy for refractory intracranial hypertension. Neurocrit Care. 2009; 11:101-105.
64. Fletcher JJ, Bergman K, Carlson G, Feucht EC, Blostein PA. Continuous renal replacement therapy for refractory intracranial hypertension? J Trauma. 2010;68:1506-1509.
65. Stewart IJ, Cotant CL, Tilley MA, et al. Association of rhabdomyolysis with renal outcomes and mortality in burn patients. J Burn Care Res. 2013;34:318-325.
66. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361:62-72.
67. Cruz DN, Bagshaw SM. Does continuous renal replacement therapy have a role in the treatment of rhabdomyolysis complicated by acute kidney injury? Semin Dial. 2011;24:417-420.
68. Finnerty CC, Jeschke MG, Herndon DN, et al. Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med. 2008;14:553-560.
69. Vindenes HA, Ulvestad E, Bjerknes R. Concentrations of cytokines in plasma of patients with large burns: their relation to time after injury, burn size, inflammatory variables, infection, and outcome. Eur J Surg. 1998; 164:647-656.
70. Peng Y, Yuan Z, LiH. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis. Burns. 2005;31:623-628.
71. McMaster P, Shann F. The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med. 2003;4:2-7.
72. Kellum JA, Bellomo R, Mehta R, Ronco C. Blood purification in non-renal critical illness. Blood Purif. 2003;21:6-13.
73. Abraham E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med. 1999;25:556-566.
74. Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27:792-801.
75. Ronco C, Ricci Z, Bellomo R. Importance of increased ultrafiltration volume and impact on mortality: sepsis and cytokine story and the role of continuous veno-venous haemofiltration. Curr Opin Nephrol Hypertens. 2001;10:755-761.
76. Yekebas EF, Eisenberger CF, Ohnesorge H, et al. Attenuation of sepsisrelated immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med. 2001;29:1423-1430.
77. Herrera-Gutierrez ME, Seller-Perez G, Arias-Verdu D, et al. A comparison of the effect of convection against diffusion in hemodynamics and cytokines clearance in an experimental model of septic shock. J Trauma Acute Care Surg. 2012.
78. Yekebas EF, Strate T, Zolmajd S, et al. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int. 2002;62:1806-1818.
79. Rimmele T, Assadi A, Cattenoz M, et al. High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant. 2009;24:421-427.
80. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of shortterm, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med. 2000;28:3581-3587.
81. Ratanarat R, Brendolan A, Ricci Z, et al. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock. Semin Dial. 2006;19:69-74.
82. Piccinni P, Dan M, Barbacini S, et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med. 2006;32:80-86.
83. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol. 2005;46:432-437.
84. Nishida O, Nakamura T, Kuriyama N, et al. Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. Contrib Nephrol. 2011; 173:172-181.
85. Nakamura M, Oda S, Sadahiro T, et al. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator. Contrib Nephrol. 2010;166:73-82.
86. Cruz DN, Antonelli M, Fumagalli R, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445-2452.
87. Venkataraman R, Subramanian S, Kellum JA. Clinical review: extracorporeal blood purification in severe sepsis. Crit Care. 2003;7:139-145.
88. Taniguchi T. Cytokine adsorbing columns. Contrib Nephrol. 2010; 166:134-141.
89. KobeY,Oda S,Matsuda K,Nakamura M,HirasawaH.Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Purif. 2007;25:446-453.
90. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis. 199z4;23:817-827.
91. Shaz BH, Linenberger ML, Bandarenko N, et al. Category IV indications for therapeutic apheresis: ASFA fourth special issue. J Clin Apher. 2007; 22:176-180.
92. Donati L, Signorini M, Busnach G, Noe L, Mazza E. Prophylactic plasma exchange in burn treatment. Int J Tissue React. 1987;9:215-218.
93. Schnarrs RH, Cline CW, Goldfarb IW, et al. Plasma exchange for failure of early resuscitation in thermal injuries. J Burn Care Rehabil. 1986; 7:230-233.
94. Warden GD, Stratta RJ, Saffle JR, Kravitz M, Ninnemann JL. Plasma exchange therapy in patients failing to resuscitate from burn shock. J Trauma. 1983;23:945-951.
95. Kravitz M, Warden GD, Sullivan JJ, Saffle JR. A randomized trial of plasma exchange in the treatment of burn shock. J Burn Care Rehabil. 1989;10:17-26.
96. Neff LP, Allman JM, Holmes JH. The use of theraputic plasma exchange (TPE) in the setting of refractory burn shock. Burns. 2010;36:372-378.
97. Klein MB, Edwards JA, Kramer CB, et al. The beneficial effects of plasma exchange after severe burn injury. J Burn Care Res. 2009;30:243-248.
98. Cruz D, Bellomo R, Kellum JA, De Cal M, Ronco C. The future of extracorporeal support. Crit Care Med. 2008;36(Suppl 4):S243-S252.